In another study, Yki-Järvinen demonstrated that liver fibrosis progression was linked to lowering hepatic ALT activity and increasing AST/ALT ratio (Yki-Järvinen, 2016 ▶). The gene discussed is GPT; the disease is Hepatic fibrosis.